Back to Results
First PageMeta Content
Pharmaceutical sciences / Merck / Pharmacology / Amides / Oxadiazoles / Raltegravir / Merck & Co. / Antiretroviral drug / Center for Drug Evaluation and Research / Food and Drug Administration / Chemistry / Integrase inhibitors


FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE HILTON WASHINGTON, DC/SILVER SPRING; 8727 COLESVILLE ROAD, SILVER SPRING, MARYLAND SEPTEMBER 5, 2007
Add to Reading List

Document Date: 2007-09-18 16:56:57

Open Document

File Size: 15,86 KB

Share Result on Facebook

City

WASHINGTON / DC / /

Company

Merck & Co. Inc. / Regulatory Affairs Merck & Co. Inc. / Clinical Research Merck & Co. Inc. / /

IndustryTerm

treatment of HIV / /

MedicalCondition

infection / /

Organization

CENTER FOR DRUG EVALUATION AND RESEARCH / FOOD AND DRUG ADMINISTRATION / Division of Antiviral Products / /

Person

Antiviral Drugs / Background Bach-Yen Nguyen / Robin Isaacs / Lynn A. Paxton / Cicely Reese / Sarah Connelly / Introductory Remarks Kendall Marcus / Robert A. Fromtling / /

Position

Federal Officer / Medical Officer / Executive Director / Director / M.P.H. Acting Chair / /

ProgrammingLanguage

DC / /

SocialTag